CD43 and CD5 antibodies define four normal and neoplastic B-cell subsets: a three-color flow cytometric study. NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


CD43 and CD5 antibodies define four normal and neoplastic B-cell subsets: a three-color flow cytometric study.

Cytometry. 1995 Sep 15;22(3):223-31. Unique Identifier : AIDSLINE MED/96106606
Lynch EF; Jones PA; Swerdlow SH; Department of Pathology, University of Pittsburgh School of; Medicine, Pennsylvania, USA.


Abstract: CD43 antibodies are best known for identifying normal and neoplastic T cells and a subset of neoplastic B cells in paraffin sections. The frequency of nonneoplastic CD43 + B cells in different reactive settings, the proportion of B-cell neoplasms with small CD43+ populations, and the relationship of CD43+ B cells was therefore studied in 138 specimens using three-color cytometric analysis. CD43 and CD5 defined four normal B-cell subsets (CD43 + CD5 +, CD43 + CD5-, CD43 - CD5+, and CD43-CD5-). A significantly greater proportion of CD43+ B cells was found in cord blood and putative HIV+ blood samples than in normal control bloods. B-cell neoplasms derived from each of these four B-cell subsets were identified, with CD43+ /CD5+ and CD43-/CD5- neoplasms being most common. The predominant B-cell population coexpressed CD43 alone in 2/39 neoplasms and CD5 alone in four. A minority of cases showed heterogeneous CD43 expression. The B cells in two of three posttransplant lymphoproliferative disorders coexpressed CD43. B cells showed weaker CD43 staining than did T-cells (relative fluorescence 0.38 +/- 0.29). These findings support the concept that CD43 expression by neoplastic B cells is not an aberrant finding. CD43 expression on normal and neoplastic B cells is independent of CD5 expression even though CD43 and CD5 are frequently coexpressed. CD43 expression by B cells sometimes might be underestimated in paraffin sections because it is much weaker than on T cells.(ABSTRACT TRUNCATED AT 250 WORDS)
Keywords: Adult Ammonium Chloride Animal Antibodies/*IMMUNOLOGY Antigens, CD19/IMMUNOLOGY Antigens, CD5/*IMMUNOLOGY B-Lymphocyte Subsets/*IMMUNOLOGY *Flow Cytometry Human Lymphoma, B-Cell/*IMMUNOLOGY Reagent Kits, Diagnostic Sialoglycoproteins/*IMMUNOLOGY Support, Non-U.S. Gov't JOURNAL ARTICLEKWDadultammoniumchlorideanimalantibodies/KWDimmunologyantigens,cd19/immunologyantigens,cd5/KWDimmunologyb-lymphocytesubsets/KWDimmunologyKWDflowcytometryhumanlymphoma,b-cell/KWDimmunologyreagentkits,diagnosticsialoglycoproteins/KWDimmunologysupport,non-uKWDsKWDgov'tjournalarticle
960530
M9651006

Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .